[TEVA] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
10-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 83.21%
YoY- 78.53%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 4,457,000 3,850,000 3,878,000 3,661,000 3,884,000 3,595,000 3,785,000 11.47%
PBT 473,000 75,000 -914,000 -258,000 -1,100,000 166,000 -1,160,000 -
Tax 41,000 -12,000 -16,000 -19,000 154,000 107,000 -900,000 -
NP 429,000 80,000 -863,000 -205,000 -1,221,000 56,000 -232,000 -
Tax Rate -8.67% 16.00% - - - -64.46% - -
Total Cost 4,028,000 3,770,000 4,741,000 3,866,000 5,105,000 3,539,000 4,017,000 0.18%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin 9.63 2.08 -22.25 -5.60 -31.44 1.56 -6.13 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS 0.41 0.07 -0.77 -0.18 -1.10 0.05 -0.21 -
EPS Diluted 0.41 0.07 -0.77 -0.18 -1.10 0.05 -0.21 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.